Perfusion SPECT/CT to diagnose pulmonary embolism during COVID-19 pandemic.
This article is part of the Topical Collection on Infection and inflammation The global pandemic of novel coronavirus disease 2019 (COVID-19) has affected the way we practice nuclear medicine [[1]]. The patients referred to nuclear medicine service for PE diagnosis usually had symptoms of dyspnea on...
| Published in: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 47; no. 9; pp. 2064 - 2066 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Published: |
Springer Nature
Aug2020
|
| Online Access: | View this record in EBSCOhost |
| Summary: | This article is part of the Topical Collection on Infection and inflammation The global pandemic of novel coronavirus disease 2019 (COVID-19) has affected the way we practice nuclear medicine [[1]]. The patients referred to nuclear medicine service for PE diagnosis usually had symptoms of dyspnea on exertion and elevated D-dimer levels, which were commonly seen in both PE and COVID-19 infection [[2]]. The PE diagnosis on Q-SPECT/CT images can be made using the previously published "MSKCC Q-SPECT/CT criteria" [[8]], whereas PE is indicated by at least one wedge-shaped peripheral defect estimated as >= 50% of a pulmonary segment without corresponding CT image abnormality and clearly seen in all three orthogonal planes. |
|---|